Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation
A Non-Interventional Study to Evaluate the Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance in Patients Who Have Undergone Clareon® Vivity® IOL Implantation
clinicaltrials.govEligibility
Inclusion Criteria
- Age ≥ 18 years
- History of adult cataract and uneventful, refractive cataract surgery with Clareon® Vivity® or Vivity® Toric intraocular lens (IOL) implantation with manifest refraction spherical equivalent (MRSE) within ±1.00 D
- Willing to undergo an eye exam with pupil dilation
Exclusion Criteria
- Moderate to severe posterior capsule opacification (2+ or more)
- Yttrium aluminum garnet (YAG) laser capsulotomy within 1 month prior to enrollment
- Laser-assisted in situ keratomileusis (LASIK) or photorefractive keratectomy (PRK) within the one year prior to IOL implantation or any time after IOL implantation
- Any previous ocular surgery (excluding YAG, LASIK, PRK)
- Clinically significant ocular pathology; severe diabetic retinopathy, age-related macular degeneration (AMD), glaucoma, severe dry eye, irregular astigmatism, zonular weakness, pseudoexfoliation, ocular trauma
- Any additional procedure(s) at the same time as the Vivity implantation including but not limited to microinvasive glaucoma surgery (MIGS)
- Women who are pregnant at the time of screening (based on self-reported history)
- Medical or other problems which in the opinion of the investigator will render study participation unsafe